"Protection from within" - Heliocare Ultra Oral Capsules

Heliocare Ultra Oral Capsules supplements contain high levels of Fernblock , the natural plant extract with proven skin-specific UV protection capabilities and is boosted by Vitamin C and E and the botanically derived Lutein and Licopene. A capsule in the morning and repeated 4-6 hours later during periods of high risk can provide antioxidant protection & enhancement of the underlying skin-architecture and help protect the skin’s immunological functions and cellular DNA.

There are times when protection of the skin "from within" to enhance the use of the Heliocare topical "on-the-skin" products can be important. This is normally during times of high-level UV exposure or risk which can be due to skin-type or condition (pigmentation) an outdoor lifestyle,or impaired skin-health that can be due to a medical condition (PLE), or aesthetic or medical procedure(peel,laser)

Indication:
- Photodermatosis
- Immunosuppression treatments
- Photosensitising treatments
- Dermocosmetic procedures
- History of skin cancer
- Hyperpigmentation
- Coadyuvant in phototherapy
- Eye protection (given by Lutein)
- Cutaneous intolerance to sunlight

Heliocare Ultra Oral Capsules are proven to provide a clinically significant reduction in UV allergic skin reactions such as PLE. Polymorphic light eruption (PLE) is the most common photosensitive disorder, affecting up to 20% of individuals with women being more commonly affected than men. It manifests as an itchy and painful rash, which is often confused with ‘prickly heat. PLE rashes appear upon exposure to sunlight and can last anywhere between 1 and 7 days.

Heliocare Ultra Oral Capsules clearly show a skin-specific anti-oxidant activity, fibroblast and collagen protection, langerhan cell protection, DNA protection and repair and a clinically significant reduction in UV allergic skin reactions such as PLE.This is due to the unique and patented Fernblock™ Photoimmunoprotection Technology. Fernblock™, an extract from a tropical fern, P. leucotomos is a key ingredient in the Heliocare range.


Studies conducted on patients affected with PLE:

Caccialanza et al (2007) demonstrated that Heliocare Ultra Oral Capsules could help reduce different types of UV-induced skin reactions in patients who had previously been unresponsive to other treatments. 80% of the patients who completed the study showed an improvement in their condition with 31% showing a complete normalisation with no occurrences of skin reactions upon UV exposure.

In 2010, Tanew et al, investigated the effects of Heliocare Ultra Oral Capsules on patients severely affected with PLE. 30 patients receiving Heliocare Ultra Oral Capsules daily showed substantial reduction in the frequency of occurrence of PLE lesions following UVA and UVB exposure and also a significant delay in their formation.

Recent clinical research conducted by Dr Venturini looked at the use of Heliocare Ultra Oral Capsules in reducing one of the most common UV related skin health problems, Polymorphic Light Eruptions (PLE). All of the 10 patients who took part in their study developed PLE lesions after repeated irradiation with UVA. Of these, five patients also developed PLE lesions after UVB radiation. The study found that a 67% increase in the level of UV radiation was required to induce a response following the introduction of Heliocare Ultra Oral Caspules, the PLE
reaction witnessed was also less severe than that at the start of the study.

10% OFF ALL HELIOCARE PRODUCTS THROUGHOUT AUGUST